We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
These results support further studies on TROP-2 as a therapeutic and diagnostic target for mCRPC.
No takes yet. Share an insight, caveat, or question.
Sperger et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: